Shehnaaz Suliman
Directeur/Membre du Conseil chez ULTRAGENYX PHARMACEUTICAL INC.
Fortune : 775 401 $ au 30/04/2024
Postes actifs de Shehnaaz Suliman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Directeur/Membre du Conseil | 30/01/2019 | - |
| Independent Dir/Board Member | 30/01/2019 | - | |
| 10X GENOMICS, INC. | Directeur/Membre du Conseil | 01/08/2019 | - |
| Independent Dir/Board Member | 01/08/2019 | - | |
Executive Women in Bio
 Executive Women in Bio Miscellaneous Commercial ServicesCommercial Services Executive Women in Bio provides mentoring program services to support women in various stages of career and personal development. | Président | - | - |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Directeur/Membre du Conseil | 11/01/2022 | - |
| Directeur Général | 11/01/2022 | - |
Historique de carrière de Shehnaaz Suliman
Anciens postes connus de Shehnaaz Suliman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALECTOR, INC. | Directeur Général | 11/12/2019 | 15/12/2021 |
| Directeur des opérations | 11/12/2019 | 01/01/2022 | |
| President | 11/12/2019 | 15/12/2021 | |
Parvus Therapeutics, Inc.
 Parvus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Parvus Therapeutics, Inc. manufactures and sells biopharmaceutical products. The private company is based in Calgary, Canada. | Directeur/Membre du Conseil | 01/10/2017 | 01/07/2019 |
| THERAVANCE BIOPHARMA, INC. | Corporate Officer/Principal | 01/07/2017 | 31/03/2019 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/06/2015 | 01/07/2017 |
Formation de Shehnaaz Suliman
| University of Oxford | Graduate Degree |
| University of Cape Town | Doctorate Degree |
| Saïd Business School | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 7 |
| Royaume-Uni | 3 |
| Suisse | 2 |
Opérationnelle
| Director/Board Member | 4 |
| Corporate Officer/Principal | 2 |
| Masters Business Admin | 2 |
Sectorielle
| Health Technology | 8 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| 10X GENOMICS, INC. | Health Technology |
| THERAVANCE BIOPHARMA, INC. | Health Technology |
| ALECTOR, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Health Technology |
Parvus Therapeutics, Inc.
Parvus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Parvus Therapeutics, Inc. manufactures and sells biopharmaceutical products. The private company is based in Calgary, Canada. | Health Technology |
Executive Women in Bio
Executive Women in Bio Miscellaneous Commercial ServicesCommercial Services Executive Women in Bio provides mentoring program services to support women in various stages of career and personal development. | Commercial Services |
- Bourse
- Insiders
- Shehnaaz Suliman
- Expérience